POINT BIOPHARMA GLOBAL INC shareholders Q3 2023

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.

POINT BIOPHARMA GLOBAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 9,954$66,3930.04%
JUPITER ASSET MANAGEMENT LTD 524,079$3,495,6070.04%
CORNERCAP INVESTMENT COUNSEL INC 28,474$189,9220.04%
THRIVENT FINANCIAL FOR LUTHERANS 1,106,042$7,3770.02%
Claro Advisors LLC 10,920$72,8360.02%
Yarbrough Capital, LLC 42,130$281,0070.02%
Point72 Asset Management, L.P. 789,100$5,263,2970.02%
PROFUND ADVISORS LLC 38,551$257,1350.01%
MARTINGALE ASSET MANAGEMENT L P 101,566$677,4460.01%
GW HENSSLER & ASSOCIATES LTD 24,056$160,4540.01%
Baker Brothers Advisors 249,968$1,667,2870.01%
FEDERATED HERMES, INC. 547,433$3,651,3780.01%
Rafferty Asset Management, LLC 223,080$1,487,9440.01%
WINTON GROUP Ltd 16,056$107,0940.01%
GSA CAPITAL PARTNERS LLP 13,987$930.01%
AQR Capital Management 552,753$3,686,8630.01%
Clear Harbor Asset Management, LLC 10,000$66,7000.01%
Connor, Clark & Lunn Investment Management Ltd. 213,865$1,426,4800.01%
E Fund Management Co., Ltd. 11,463$760.01%
BLAIR WILLIAM & CO/IL 250,528$1,671,0220.01%
External links

This page lists POINT BIOPHARMA GLOBAL INC's shareholders in Q3 2023. To view POINT BIOPHARMA GLOBAL INC's shareholder history, click here.